Panome Bio Introduces MassID™, a Major Advance in Untargeted Metabolomics Data Analysis for Biomarker Discovery and Drug Development

Panome Bio, a leading multi-omics contract research organization, today announced the launch of MassID™, a cloud-based ...
AlphaGalileo

Beyond a single genome: Mapping structural variation in papaya

Papaya (Carica papaya L.) is a globally important tropical fruit valued for its nutrition and medicinal properties, yet its genetic diversity has ...
PharmiWeb

IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities

IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced it has ...
The Manila Times

Ivim Health GLP-1 Weight Loss Program: Individualized Dosing, Pricing, and What Consumers Should Know in 2026

An informational overview of Ivím Health's compounded semaglutide and tirzepatide telehealth program, including GLP-1 ID cost breakdown, weekly provider check-in structure, clinical claims analysis, a ...

Lesch-Nyhan Syndrome: Trapped inside own impulses

Rare diseases often hide in plain sight — behind delayed milestones, feeding difficulties or symptoms that seem minor at first glance. Lesch-Nyhan Syndrome (LNS ...
The Lancet

Paediatric trial guidelines co-designed by those who take part

In paediatrics, “more trials have been done over the last ten years, but we have struggled with transparency and clarity, and sometimes with the quality because they are not always asking the ...
NetIndia123

First time in India, Genetic Wellness Testing at Rs 999, launched by NuGenomics - AI driven Wellness Startup

Leg-spinner Yuzvendra Chahal's maiden six-wicket for India as the hosts beat England by 75 runs in the third and final Twenty20 International ...
Frontiers

Cellular cross-talk in neuromuscular diseases and targets for therapeutic intervention

Neuromuscular diseases comprise a heterogeneous group of disorders characterized by progressive impairment of muscle function resulting from defects in ...
PharmExec

Pharma Mergers and Acquisitions Roundup: Novo Nordisk Enters $2.1 Billion Partnership with Vivtex, GSK Enters $950 Million Acquisition Agreement with 35Pharma Inc.

Novo Nordisk partners with Vivtex Corporation to develop next-generation oral biologics for obesity and diabetes, while GSK agrees to acquire 35Pharma Inc. to expand its pulmonary hypertension ...
News-Medical.Net

Using Artificial Intelligence to Predict Chronic Disease Through Diet and Multi-Omics Data

Discover how AI is transforming nutritional science by turning complex diet and omics data into predictive tools that reshape chronic disease prevention and personalized care.
Frontiers

Glucose–Lipid Metabolic Dysfunction and Skeletal Fragility: Bone Quality, Repair Biology, and Targeted Endocrine/Metabolic Interventions

Glucose–lipid metabolic dysfunction, increasingly prevalent with the worldwide rise in obesity, type 2 diabetes, and aging, has emerged as a critical factor ...
Scientific Research Publishing

Primary Hyperparathyroidism and Pregnancy about a Case: Association at Risk for the Mother and Fetus ()

Share and Cite: Cisse, A. , Dieme, M. , Gassama, O. , Samb, M. and Diouf, A. (2026) Primary Hyperparathyroidism and Pregnancy about a Case: Association at Risk for the Mother and Fetus. Open Journal ...